Flecainide (Antiarrhythmic Medicine) – Patient Information (Australia)

Flecainide is a prescription antiarrhythmic medicine used to help control certain abnormal heart rhythms. This guide is designed to be clear and patient-friendly, explaining what it does, how it works in the body, typical uses, important precautions, and practical tips for safe day-to-day use in Australia.

Please note: Heart rhythm medicines can be complex and highly individual. Always follow the instructions provided by your treating clinician and the product information (consumer medicine information) supplied with your medicine.

Basic product information

How flecainide works (mechanism of action)

Flecainide is an antiarrhythmic that primarily works by blocking sodium channels in heart muscle cells. This:

• Slows electrical conduction through the heart (especially within the ventricular muscle)
• Helps stabilise the heart’s rhythm and reduce abnormal rapid beats
• Can reduce or prevent episodes of certain tachyarrhythmias (fast rhythms)

Because it affects the heart’s electrical system, it can also prolong conduction and, in some situations, may increase the risk of more serious rhythm disturbances. That is why selection of suitable patients and monitoring (e.g., ECG) are central to safe use.

Pharmacokinetics: how your body handles flecainide

Pharmacokinetics describes how the body absorbs, distributes, metabolises, and eliminates a medicine. Understanding this can help explain timing, dose adjustments, and why monitoring is important.

• Absorption: Flecainide is absorbed after oral dosing. Peak blood levels typically occur within a few hours (exact time can vary by formulation and individual factors).
• Distribution: Flecainide distributes into body tissues, including the heart.
• Metabolism: It is metabolised mainly in the liver.
• Elimination: It is cleared from the body via kidney and other pathways. Clearance may be slower in kidney impairment.
• Half-life: The half-life can be several hours (and may be longer in kidney impairment or in older adults), meaning missed doses and drug accumulation can matter.

What this means for you: If your kidneys or liver are not working as well as usual, blood levels may build up more than expected, increasing the risk of side effects. Clinicians may use ECG and blood tests to guide dosing.

Typical use and indications

Flecainide is used to treat specific abnormal heart rhythms in carefully selected patients. Indications depend on local product information and clinical assessment. Common rhythm conditions considered for flecainide include:

• Paroxysmal atrial fibrillation (episodes that start and stop) in appropriate patients
• Paroxysmal atrial flutter
• Recurrent supraventricular tachycardias (fast rhythms arising above the ventricles) in selected cases
• Sometimes certain ventricular arrhythmias under specialist supervision where benefits outweigh risks

Important: Flecainide is not suitable for everyone with arrhythmias. In particular, it may be risky in some patients with structural heart disease or certain ECG findings. Your clinician will assess your heart function, prior heart attacks, and ECG parameters before considering it.

When to take flecainide (timing and routine)

Take flecainide exactly as directed on your prescription instructions and the product label.

General timing tips

• Try to take it at the same times each day to maintain steady drug levels.
• If you take it twice daily, aim for an even spacing (e.g., morning and evening).
• If you take it once daily, keep it consistent with your daily routine.

If you miss a dose

If you miss a dose, follow your clinician/pharmacist’s advice. In general, for many medicines, the approach may be:

• Take it when you remember if it is close to the next dose—but avoid doubling up.
• If it’s almost time for the next dose, skip the missed dose and resume your schedule.

Because flecainide affects heart rhythm, it’s best to ask your pharmacist for the safest specific instructions for your regimen.

Food interactions

For most patients, flecainide can generally be taken with or without food. However, consistency helps:

• If you notice side effects when taken one way, keep to your usual routine.
• Tell your clinician if your diet changes significantly (e.g., sudden weight loss, major changes in intake), as this may influence overall health and drug handling.

Key point: Food is usually not the main interaction concern for flecainide—rather, other medicines that affect heart rhythm and drug metabolism are often more important.

Alcohol and flecainide interactions

Alcohol does not directly “react” with flecainide the way some drug interactions do, but it can still affect safety.

• Alcohol can trigger arrhythmias in some people (often described as “holiday heart” effects).
• Alcohol may worsen dizziness, fatigue, or blurred vision—possible side effects of flecainide.
• If you drink alcohol while taking flecainide, do so cautiously and consider limiting intake.

Safety advice: If you notice palpitations, light-headedness, or worsening rhythm symptoms after alcohol, avoid alcohol and seek medical advice promptly.

Medicine interactions (important)

Flecainide has significant interaction potential. Always tell your pharmacist and clinician about all medicines you take, including over-the-counter products, vitamins, herbal preparations, and “natural” supplements.

Common interaction themes

• Medicines that affect heart rhythm (QT/PR or conduction effects): can increase the risk of abnormal rhythms.
• Medicines that alter flecainide levels: drugs that inhibit or induce liver metabolism may raise or lower flecainide concentration.
• Medicines that affect heart rate or conduction: combining may change ECG parameters.

Examples of medicines that may interact (not exhaustive)

• Other antiarrhythmics (especially if combined without close monitoring)
• Some antidepressants and antipsychotics that affect conduction/heart rhythm
• Some antibiotics and antifungals known to interact with drug metabolism or prolong conduction
• Certain seizure medicines (some can lower flecainide levels; others can increase risk depending on the combination)
• Medicines for heart failure or rate control may require dose adjustments
• Electrolyte-altering medicines such as diuretics can change potassium levels, which affects arrhythmia risk

Always check: Before starting, stopping, or changing any medicine, ask your pharmacist whether it could affect flecainide.

Dosing: how flecainide is commonly prescribed

Dose depends on your specific heart rhythm problem, age, kidney function, liver function, ECG results (including QRS duration), and whether you take interacting medicines.

Typical dosing approach (general guidance): Flecainide is often started at a lower dose and adjusted based on response and safety monitoring. It is usually prescribed in divided doses to maintain effective blood levels.

Factors that can change your dose

• Kidney impairment: may require a lower dose or longer intervals.
• Liver impairment: may require caution or dose adjustment.
• ECG changes: clinicians monitor conduction times and overall rhythm response.
• Electrolytes: low potassium or magnesium can increase arrhythmia risk.
• Other interacting medicines: may increase flecainide exposure.

Do not adjust your dose yourself. If your symptoms are not controlled or side effects occur, contact your clinician rather than changing the regimen independently.

Safety profile: side effects and when to seek help

Like all medicines, flecainide can cause side effects. Many people experience none or mild effects, but the potential for serious rhythm changes means it is important to know what to watch for.

Common or expected side effects

• Dizziness or light-headedness
• Headache
• Blurred vision or visual disturbances
• Nausea
• Tiredness or fatigue

Serious risks (seek urgent medical attention)

Contact emergency services or seek urgent medical care if you experience:

• Fainting or near-fainting
• Severe or worsening palpitations or feeling your heart is “racing”
• Chest pain or shortness of breath
• New weakness on one side, trouble speaking, or signs of stroke
• Very slow heartbeat with symptoms (e.g., dizziness, collapse)

When to call your clinician promptly

• New or worsening symptoms of arrhythmia despite taking the medicine correctly
• Persistent dizziness, significant visual changes, or troublesome fatigue
• Symptoms that suggest electrolyte imbalance (e.g., persistent vomiting/diarrhoea while on diuretics)

Monitoring is important: Your clinician may perform ECG checks after starting or adjusting dose and periodically thereafter.

Practical use tips for daily life

1) Keep track of symptoms

• Write down episodes of palpitations: time, duration, triggers, and associated symptoms (dizziness, breathlessness).
• Bring this log to appointments.

2) Know your baseline heart information

• Ask your clinician about your ECG details (e.g., QRS duration, PR interval) and what changes are expected with treatment.
• Carry information about your condition and medicines in case of emergency.

3) Be careful with “new” medicines

• Always check interactions before starting any new prescription, over-the-counter medicine, or supplement.
• If you have a pharmacist consult available, use it when your medication list changes.

4) Support stable health habits

• Stay hydrated, particularly if you experience illness with vomiting or diarrhoea.
• Follow your clinician’s advice about managing electrolytes and any fluid restrictions.
• Get regular sleep and manage stress, as these can influence rhythm stability.

5) Pregnancy and breastfeeding (general caution)

If you are pregnant, planning pregnancy, or breastfeeding, discuss flecainide with your clinician. The suitability depends on your heart condition and the balance of risks and benefits.

Alternative options for atrial or supraventricular rhythm control

Depending on your rhythm problem, health history, and ECG findings, clinicians may consider alternatives to flecainide. Options can include:

• Other antiarrhythmic medicines (selection varies widely based on whether you have structural heart disease and other risk factors)
• Rate control medicines (aim to slow the heart rate rather than restore normal rhythm)
• Catheter ablation (non-medicinal option for some arrhythmias)
• Cardioversion (a procedure to restore normal rhythm in selected cases)
• Management of triggers such as thyroid disease, alcohol excess, sleep apnoea, or electrolyte imbalance

Which option is best for you depends on the type of arrhythmia and your overall cardiac health. If flecainide is not suitable or not effective, ask your clinician about the most appropriate alternatives.

Australia: market and legal context

In Australia, flecainide is regulated as a prescription medicine. This means supply is managed through pharmacy systems with appropriate clinical oversight. Requirements can vary by product brand and formulation, but the key expectation is that clinicians assess suitability and safety before initiation.

Dispensing and monitoring: Because flecainide can affect cardiac conduction and rhythm, Australian healthcare providers commonly arrange ECG monitoring and review your medicines for interactions.

Quality and safety standards: Medicines supplied in Australia are subject to regulatory standards and quality assurance processes through the Australian medicines regulatory framework.

Recent guidance and clinical practice considerations (overview)

Clinical practice for arrhythmia management evolves as new evidence and safety information emerges. While the core safety principles for flecainide remain consistent—careful patient selection, ECG monitoring, and attention to drug interactions—current practice often emphasises:

• Confirming the arrhythmia type (e.g., atrial fibrillation vs flutter vs other tachycardias)
• Assessing for structural heart disease and risk factors before use
• Reviewing interaction risks (including medicines that raise flecainide levels or affect conduction)
• Regular ECG and symptom follow-up after starting or adjusting dose
• Individualised benefit–risk assessment, especially in older adults and those with kidney impairment

Your treating team may also align treatment with broader atrial fibrillation and rhythm management recommendations used in Australia and internationally.

Delivery and availability in Australia (online pharmacy)

Flecainide availability can vary by brand and strength. When ordering online from an Australian pharmacy, typical steps include:

• Checking stock and expected dispatch time (some items may be supplied from distribution centres)
• Packaging for safe transport, with clear labels and dosing instructions
• Delivery tracking and estimated delivery windows

Delivery times: Delivery speed depends on location (metro vs regional), courier service, and whether the product is held in local stock. If the medicine is not immediately available, the pharmacy may offer alternatives such as ordering from the supplier or providing an equivalent brand if appropriate.

Availability considerations: Always ensure you order the correct strength and formulation (e.g., tablet strength and your prescribed regimen). If you are unsure, contact the pharmacy before placing the order.

Safety checklist before you start (or when you restart)

• Have you had a recent ECG or assessment as advised by your clinician?
• Have you provided your pharmacist with a complete list of medicines and supplements?
• Have your kidney function results (and electrolytes if relevant) been considered?
• Do you know what symptoms mean “call your doctor” versus “seek emergency help”?
• Do you understand your dosing schedule and timing?

FAQ: Flecainide (Patient Questions)

1) What is flecainide used for?

Flecainide is used to help control certain abnormal heart rhythms, such as paroxysmal atrial fibrillation or flutter and other selected supraventricular arrhythmias. Suitability depends on your specific diagnosis and cardiac history.

2) How quickly does flecainide work?

Some people notice rhythm improvement within hours to days, but response varies widely. Clinicians typically assess effectiveness over time and may use ECG monitoring to evaluate how the medicine is affecting conduction.

3) Can I stop flecainide if my symptoms improve?

Do not stop flecainide without advice from your clinician. Stopping suddenly can allow arrhythmias to return or worsen. If you’re considering stopping, discuss a plan with your treating team.

4) What should I do if I feel dizzy after taking flecainide?

If dizziness is mild and temporary, monitor symptoms and contact your clinician or pharmacist for advice. If you feel faint, have chest pain, or have worsening palpitations, seek urgent medical attention.

5) Does flecainide interact with other heart medicines?

Yes, it can. Some medicines that affect heart rhythm, conduction, or drug metabolism may increase risks. Provide your full medicine list to your pharmacist before starting or changing any medicines.

6) Can I drink alcohol while taking flecainide?

Alcohol can trigger arrhythmias in some people and may worsen dizziness or fatigue. If you choose to drink, do so cautiously and avoid excess. If alcohol seems to trigger palpitations, it’s best to avoid it and seek advice.

7) Is flecainide safe for people with all types of heart disease?

No. Flecainide is not suitable for everyone, especially those with certain structural heart conditions or risk profiles. Your clinician will assess your ECG and heart function before prescribing.

8) What monitoring will I need?

Often this includes ECG checks and review of symptoms after starting or adjusting the dose. Kidney function and electrolyte status may also be considered, especially in those with kidney impairment or taking medicines that affect electrolytes.

9) Can flecainide be taken with food?

It is generally taken with or without food. Keeping a consistent routine can help you manage side effects and maintain steady daily use.

10) Are there alternatives if flecainide doesn’t work for me?

Yes. Depending on your arrhythmia, options may include other antiarrhythmic drugs, rate control strategies, or procedural options such as catheter ablation. Your clinician can help determine the best alternative based on your diagnosis and risk factors.

Important reminder: Flecainide affects heart electrical activity. If you experience severe symptoms such as fainting, chest pain, shortness of breath, or markedly worsening palpitations, seek urgent medical care immediately.